September 23, 2017 8:42 PM ET

Life Sciences Tools and Services

Company Overview of Goodwin Biotechnology, Inc.

Company Overview

Goodwin Biotechnology, Inc., a biological contract manufacturing organization, provides a range of mammalian cell culture development and manufacturing services. The company focuses on the research, development, manufacture, and validation of cytotoxic antibody drug conjugates, radioimmunoconjugates, monoclonal antibodies, recombinant proteins, vaccines, and other biologic drug conjugates for early and late stage clinical trials. It offers cell culture development, purification, bioconjugation, biosimilars, process development and cGMP manufacturing, and aseptic filling and finishing services. The company also provides support services, such as assay development, quality control and assuranc...

1850 N.W. 69th Avenue

Plantation, FL 33313

United States

Founded in 1992

Phone:

954-327-9656

Fax:

954-587-6378

Key Executives for Goodwin Biotechnology, Inc.

Chief Executive Officer
Co-Founder and Executive Vice President of Client Operations
Chief Operating Officer
CSO and Vice President of Bioconjugation Development
Executive Vice President of Regional Affairs, Quality Assurance and Quality Control
Compensation as of Fiscal Year 2017.

Goodwin Biotechnology, Inc. Key Developments

Goodwin Biotechnology, Inc. Enters into Agreement with Minneapolis Medical Research Foundation

Goodwin Biotechnology, Inc. has entered into an agreement with the Minneapolis Medical Research Foundation (MMRF) to develop vaccines to treat heroin and prescription opioid addiction and ready these vaccines for clinical evaluation. This research is funded by a three-year grant to the MMRF from the National Institute on Drug Abuse. This agreement enables Goodwin Biotech and MMRF to develop vaccines to provide an additional option for treating opioid addiction.

The Minneapolis Medical Research Foundation Selects Goodwin Biotechnology to Help Develop and Manufacture Two Vaccines to Treat Opioid Addiction

Goodwin Biotechnology, Inc. announced that it was selected by the Minneapolis Medical Research Foundation to help develop vaccines to treat heroin and prescription opioid addiction and ready these vaccines for clinical evaluation. This research is funded by a three-year grant to the research foundation from the National Institute on Drug Abuse.

International Biotechnology Center Generium Selects Goodwin Biotechnology

International Biotechnology Center 'Generium' has selected Goodwin Biotechnology for the assay and process technology transfer, process scale-up, and cGMP manufacturing of an IgG-based, bispecific antibody to support early stage clinical trials.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Goodwin Biotechnology, Inc., please visit www.goodwinbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.